Filter
166
Filtered Results: 166
Text search:
S
.Gulati
Featured
Recommendations
17
New Publications
40
Language
Document type
No document type
91
Guidelines
36
Studies & Reports
17
Manuals
10
Fact sheets
3
Training Material
2
Brochures
2
Resource Platforms
2
Strategic & Response Plan
2
Infographics
1
Countries / Regions
India
19
Philippines
6
Latin America and the Carribbean
6
Bolivia
5
Mozambique
4
Brazil
4
Malawi
3
Global
3
Africa
3
Paraguay
3
Zambia
3
Nepal
2
Sierra Leone
2
Western and Central Europe
2
South Africa
2
Eastern Europe
2
Ethiopia
2
Colombia
1
Kenya
1
El Salvador
1
Turkey
1
Ghana
1
Rwanda
1
Syria
1
Nigeria
1
Peru
1
Morocco
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Tanzania
1
Germany
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Spain
1
Southern Africa
1
Bangladesh
1
Uganda
1
Russia
1
Honduras
1
Angola
1
Indonesia
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
26
Public Health
9
Women & Child Health
7
Key Resources
6
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
24
NTDs
14
Mental Health
12
HIV
10
Rapid Response
6
TB
6
Disability
4
Caregiver
4
Planetary Health
4
Pharmacy
4
Global Health Education
4
Conflict
3
Cholera
2
Specific Hazards
1
Refugee
1
Natural Hazards
1
Social Ethics
1
Polio
1
This guidance document provides basic broad principles for a spokesperson
of any health authority on how to respond to vocal vaccine deniers.
The suggestions are based on psychological research on persuasion,
on research in public health, communication studies and on WHO risk
communication guide...
Toxicologie Maroc - N° 24 - 1er trimestre 2015
La Organización Panamericana de la Salud se complace en presentar la segunda edición del Manual de procedimientos para la vigilancia y el control de las leishmaniasis en la Región de las Américas, un instrumento de apoyo a las áreas de gestión y de servicios que trabajan con la leishmaniasis e...
The “Wuppertal Call” – Contributions and Recommendations from an
International Conference on Eco-Theology and Ethics of Sustainability
Wuppertal, Germany, 16 – 19 June 2019
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
Growing evidence indicates that large proportions of children around the world experience physical, sexual and emotional violence every year, with enormous implications for human rights, public health and economic and social development.1 Over the last five years, national governments and Together f...
RBC/IHDPC/ EID Division | November 2011 - Ce manuel de procédure vise à
guider les professionnels de soins de santé et des experts en santé publique de différents niveaux du système de santé dans la mise en œuvre de la surveillance renforcée de la méningite cérébrospinale.
El Laboratorio de Micología del Centro Nacional de Salud Pública del Instituto Nacional de Salud (INS) ha elaborado el presente manual de procedimientos micológicos, a fin de actualizar y uniformizar los conocimientos referidos al diagnóstico micológico que se basa en la identificación precisa...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
A Global Inventory of Alternative Medical Waste Treatment Technologies
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
